Man Group’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$469K Buy
+60,851
New +$488K ﹤0.01% 2095
2024
Q1
– Sell
-35,000
Closed -$132K – 2139
2023
Q4
$132K Buy
+35,000
New +$120K ﹤0.01% 1960
2023
Q1
– Hold
0
– – – 1974
2021
Q3
– Sell
-13,100
Closed -$90K – 1929
2021
Q2
$90K Buy
+13,100
New +$104K ﹤0.01% 1867

Other funds holding CRMD

Man Group's CRMD Position: Q3 2026 in Review

Man Group opened a new position in CorMedix (CRMD) in Q3 2026: 60,851 shares worth $469K. The stake represents ﹤0.01% of the portfolio and ranks #2095 among its holdings. This is a return to the name: Man Group previously reported a position in CRMD as recently as Q4 2023.

Man Group first reported a position in CRMD in Q2 2021 and has held it in 3 quarters since. 187 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • Man Group held 60,851 shares of CorMedix worth $469K as of Q3 2026.
  • CorMedix was a new Man Group position in Q3 2026.
  • CorMedix made up ﹤0.01% of Man Group's portfolio in Q3 2026, its #2095 holding.
  • Man Group first reported a position in CorMedix in Q2 2021 and has held it in 3 quarters since.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on Man Group's 13F filing for Q3 2026, filed 16 Nov 2026.